Author:
Mukala Joseph,Mogere Dominic,Kirira Peter,Kanoi Bernard N.,Akinyi Violet,Kobia Francis,Waweru Harrison,Gitaka Jesse
Abstract
AbstractIntermittent preventive treatment remains a core strategy for malaria prevention in pregnancy. Sulfadoxine-pyrimethamine is recommended for all pregnant women in malaria prone zones. It is scheduled monthly at each antenatal care visit up to 36 weeks. Here, we sought to assess the knowledge, attitude and practices on intermittent preventive treatment in pregnant women with malaria in Webuye hospital. Prior to the enrollment, ethical approval and permissions were sought from relevant institutions, as well as consents obtained from 140 participants aged between 18-49 years with gestation about 16 weeks. Malaria test was conducted via either microscopy or rapid test and participants were split into malaria positive and negative cohorts. Closed and open-ended questionnaire were administered to the participants and two focus group discussions were organized to collect their views. The results were expressed in percentage and Chi-square of association at a p-value equal or less than 0.05 (95%). Qualitative data were analyzed by the means of MAXQDA software. Our analysis revealed that there was a significant difference between the proportion of negative and positive groups among mothers’ knowledgeable on the side effects (p-value = 0.001), different doses (p-value = 0.012). Those who were informed about intermittent preventive treatment before administration (p-value = 0.003). The proportion of mothers knowledgeable about side effects and different doses were higher among the malaria positive group as compare to the negative with 52.9% versus 25.7% and 20.0% versus 5.7% respectively. Moreover, 76.3% of respondents reported that intermittent preventive treatment prevents malaria, 30.9% had the opinion that it causes abortion. Expectant women who were aware of the benefits of this strategy had this to say; “This medicine helps to reduce the effects of malaria and prevents mother to contract malaria”.However, those unaware had this to say;“I have never been told about something like that but it prevents diseases”. Those whoknew about the schedule and side effects said“It is given three doses during each antenatal visit”.Therefore, good knowledge, attitude and practices of intermittent preventive treatment are key for control and prevention of malaria in endemic prone areas.
Publisher
Cold Spring Harbor Laboratory
Reference25 articles.
1. Sohail, M. , Shakeel, S. , Kumari, S. , Bharti, A. , Zahid, F. , Anwar, S. , Raziuddin, M . (2015). Prevalence of malaria infection and risk factors associated with anaemia among pregnant women in semi urban community of Hazaribag, Jharkhand, India. BioMed research international.
2. WHO Policy Brief for the Implementation of Intermittent Preventive Treatment of Malaria in Pregnancy Using Sulfadoxine-pyrimethamine (IPT-SP). Geneva, 24. Switzerland: World Health Organization; 2014.
3. The Kenya Malaria Strategy 2009–2018 (Revised 2014). Nairobi, Kenya: Ministry of Health.
4. Factors affecting the delivery, access, and use of interventions to prevent malaria in pregnancy in sub-Saharan Africa: A systematic review and meta-analysis;PLoS Med,2013
5. Kenya Demographic and Health Survey, 2022